Kapitalforeningen Accunia Invest
Bestyrelsen i Kapitalforeningen Accunia Invest har godkendt nedennævnte udlodninger for fjerde kvartal af 2020. Udlodningerne vil formelt set blive endeligt godkendt på foreningens ordinære generalforsamling.
De optjente udbytter er vist i nedenstående tabel. Tallene er beregnet pr. 31. december 2020 og opgjort i kr. pr. investeringsbevis.
| ISIN | Kortnavn | Andelsklasse/afdeling | DKK/andel |
| DK0060804136 | ACACIGDKK | European CLO Investment Grade | 5 |
| DK0060804052 | ACAECO | European CLO Opportunity KL | 13 |
| DK0061149036 | ACKEHY | European High Yield KL | 15 |
Tidsplan
22. januar 2021 Sidste dag for handel med beviser inkl. udbytte for 4. kvartal 2020
25. januar 2021 Udbyttet fragår, og investeringsbeviserne handles uden udbytte for 4. kvartal 2020
27. januar 2021 Udbyttet er til disposition på investors konto
Kontaktperson(er):
Direktør Caspar Møller, tlf. +45 3332 7070.
Yderligere oplysninger om Kapitalforeningen Accunia Invest findes på www.accunia.com.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Digitalist Group Oyj8.1.2026 18:39:00 CET | Press release
Digitalist Group Plc - Managers' Transactions
Flow Traders Ltd8.1.2026 17:45:00 CET | Press release
Flow Traders 4Q 2025 Pre-Close Call
SCOR8.1.2026 17:36:45 CET | Press release
SCOR Global Reinsurance Ireland dac becomes SCOR Global Reinsurance France SA
Aspo Plc8.1.2026 17:30:00 CET | Press release
Aspo Plc: Share repurchase 8.1.2026
ALK Abello8.1.2026 17:17:29 CET | Press release
ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
